Phase 1 study

By invitation Phase 1

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status By invitation
Phase Phase 1
Sponsor Chugai Pharmaceutical
Registry number NCT06723106
Started 9 December 2024 Today 16 October 2026 Estimated completion 28 February 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Royal Prince Alfred Hospital Camperdown NSW Status not stated
Westmead Hospital Sydney NSW Status not stated
Campbelltown Public Hospital Sydney NSW Status not stated
The Alfred Hospital Melbourne VIC Status not stated
Box Hill Hospital Melbourne VIC Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 85 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 144

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

1. Signed informed consent form

2. Have completed 4 doses of RAY121 administrations in RAY902CT trial and shown clinical responses

3. Ability to comply with the study protocol, in the investigator's judgment

4. For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use highly effective contraceptive methods during the treatment period and 20 weeks (140 days) after the last dose of RAY121

5. For men: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive measures, and agreement to refrain from donating sperm

Exclusion Criteria:

1. History of anaphylaxis or hypersensitivity to a biologic agent

2. Known active infection with encapsuled bacteria

3. History of Neisseria meningitidis infection

4. Planned surgery

5. Pregnant or breastfeeding, or intending to become pregnant

6. Clinically significant electrocardiogram abnormalities

7. Illicit drug or alcohol abuse

8. Known or suspected immune deficiency

9. Treatment with investigational therapy other than RAY121

10. Vaccination with a live vaccine within 4 weeks

Dates on the record

Started 9 December 2024
Estimated completion 28 February 2028
Registry last updated 17 July 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 17 July 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.